Conshohocken, PA, United States of America

Valerie A Mackner


Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 147(Granted Patents)


Company Filing History:

goldMedal4 out of 1,309 
 
Wyeth
 patents
silverMedal1 out of 134 
 
Ligand Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Valerie A. Mackner: Innovator in Pharmaceutical Chemistry

Introduction

Valerie A. Mackner is a distinguished inventor based in Conshohocken, PA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. Her work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

One of her notable inventions is related to cyanopyrroles, which provides a progesterone receptor antagonist. This invention features a complex chemical structure where various groups can be substituted, allowing for a range of potential applications in medicine. The detailed formula includes components such as T, R, and n, which can vary to create different molecular configurations. This work exemplifies her commitment to advancing pharmaceutical science through innovative chemical solutions.

Career Highlights

Throughout her career, Valerie has worked with prominent companies, including Wyeth. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to drive innovation in drug development.

Collaborations

Valerie has collaborated with notable professionals in her field, including Mark A. Collins and Jay Edward Wrobel. These partnerships have further enhanced her research and development efforts, contributing to her success as an inventor.

Conclusion

Valerie A. Mackner's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading innovator in the industry. Her work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…